The Indian drug and medical device regulatory agency, the Central Drugs Standard Control Organization (CDSCO), has issued draft guidance explaining licensing requirements for devices manufactured within the country. Stakeholders have 20 days to submit feedback on the proposed guideline, which was ...
Please Login to read the full article.
